Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in TMO — Thermo Fisher Scientific Inc.

CIK 861177 NEW YORK, NY

Position in TMO

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$1,204,099,562
-$203,228,612 QoQ
Shares Held
2,449,697
+0.9% QoQ
Ownership
0.659%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 46.460072408955064.ToString("F0")% Shared 0.ToString("F0")% None 53.539927591044936.ToString("F0")%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,972,110,878 across 32 Diagnostics & Research names. TMO ranks #1 (24.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
This page
2,449,697 $1,204,099,562

All Filings in TMO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,204,099,562 2,449,697
2025-12-31 $1,407,328,174 2,428,731
2025-09-30 $1,171,324,749 2,415,003
2025-06-30 $1,245,996,007 3,073,043
2025-03-31 $1,368,859,279 2,750,923
2024-12-31 $1,259,450,290 2,420,949
2024-09-30 $1,338,268,146 2,163,487
2024-06-30 $1,185,604,903 2,143,951
2024-03-31 $920,446,578 1,583,673
2023-12-31 $855,351,622 1,611,469
2023-09-30 $864,590,994 1,708,104
2023-06-30 $860,437,745 1,649,138
2023-03-31 $950,513,663 1,649,138
2022-12-31 $1,027,567,159 1,865,963
2022-09-30 $948,278,937 1,869,672
2022-06-30 $1,155,559,812 2,127,006
2022-03-31 $1,149,127,288 1,945,530
2021-12-31 $1,404,271,294 2,104,597
2021-09-30 $1,634,850,506 2,861,482
2021-06-30 $1,218,587,636 2,415,580
2021-03-31 $1,038,349,838 2,275,187
2020-12-31 $1,038,567,827 2,229,739
2020-09-30 $1,256,910,741 2,846,781
2020-06-30 $1,042,022,801 2,875,815
2020-03-31 $832,371,668 2,935,020